Evidence map›Paper›PMID 29659747›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread.

David W Eyre, Kerrie A Davies, Georgina Davis, Warren N Fawley, Kate E Dingle, Nicola De Maio, Andreas Karas, Derrick W Crook, Tim E A Peto, A Sarah Walker and 2 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Influence of COVID-19 on Clinical Outcomes ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Pangenome-GWAS analysis ofCanadian journal of microbiology · 2026
    Article
  5. Article
  6. Changes in the Epidemiology of Clostridioides difficile Infection.Infectious disease clinics of North America · 2025
    Review
  7. Article
  8. Microbiology spectrum · 2025
    Article
  9. Microbial genomics · 2025
    Article
  10. Distribution ofEmerging microbes & infections · 2024
    Article
  11. Genomic study of EuropeanMicrobial genomics · 2024
    Article
  12. Clinical microbiology reviews · 2024
    Review
  13. Article
  14. Comparative Genomics of Clostridioides difficile.Advances in experimental medicine and biology · 2024
    Article
  15. Insights into the Evolving Epidemiology ofAntibiotics (Basel, Switzerland) · 2023
    Review
  16. Genomic epidemiology and transmission dynamics of recurrent Clostridioides difficile infection in Western Australia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  17. Article
  18. Article
  19. Sentinel surveillance and epidemiology ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  20. Make It LessGenes · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David W EyreNuffield Department of Medicine, University of Oxford.
Kerrie A DaviesHealthcare Associated Infections Research Group, University of Leeds.
Georgina DavisHealthcare Associated Infections Research Group, University of Leeds.
Warren N FawleyHealthcare Associated Infections Research Group, University of Leeds.
Kate E DingleNuffield Department of Medicine, University of Oxford.
Nicola De MaioNuffield Department of Medicine, University of Oxford.
Andreas KarasAstellas Pharma Europe, Chertsey, United Kingdom.
Derrick W CrookNuffield Department of Medicine, University of Oxford.
Tim E A PetoNuffield Department of Medicine, University of Oxford.
A Sarah WalkerNuffield Department of Medicine, University of Oxford.
Mark H WilcoxHealthcare Associated Infections Research Group, University of Leeds.
EUCLID Study Group

Funding

Department of Health DRF-2010-03-40
6 · The paper itself

Abstract

Background: Rates of Clostridium difficile infection vary widely across Europe, as do prevalent ribotypes. The extent of Europe-wide diversity within each ribotype, however, is unknown. Methods: Inpatient diarrheal fecal samples submitted on a single day in summer and winter (2012-2013) to laboratories in 482 European hospitals were cultured for C. difficile, and isolates the 10 most prevalent ribotypes were whole-genome sequenced. Within each ribotype, country-based sequence clustering was assessed using the ratio of the median number of single-nucleotide polymorphisms between isolates within versus across different countries, using permutation tests. Time-scaled Bayesian phylogenies were used to reconstruct the historical location of each lineage. Results: Sequenced isolates (n = 624) were from 19 countries. Five ribotypes had within-country clustering: ribotype 356, only in Italy; ribotype 018, predominantly in Italy; ribotype 176, with distinct Czech and German clades; ribotype 001/072, including distinct German, Slovakian, and Spanish clades; and ribotype 027, with multiple predominantly country-specific clades including in Hungary, Italy, Germany, Romania, and Poland. By contrast, we found no within-country clustering for ribotypes 078, 015, 002, 014, and 020, consistent with a Europe-wide distribution. Fluoroquinolone resistance was significantly more common in within-country clustered ribotypes (P = .009). Fluoroquinolone-resistant isolates were also more tightly clustered geographically with a median (interquartile range) of 43 (0-213) miles between each isolate and the most closely genetically related isolate, versus 421 (204-680) miles in nonresistant pairs (P < .001). Conclusions: Two distinct patterns of C. difficile ribotype spread were observed, consistent with either predominantly healthcare-associated acquisition or Europe-wide dissemination via other routes/sources, for example, the food chain.

Indexed as

Anti-Bacterial AgentsClostridioides difficileClostridium InfectionsCluster AnalysisDrug Resistance, BacterialEuropeGenetic VariationHumansRibotypingAnti-Bacterial Agents

Identifiers

PMID29659747
PMCPMC6137122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.